PM360 2018 Trailblazer Awards Gold Medical Device/Diagnostics Company of the Year Ortho Clinical Diagnostics

Ortho’s purpose is to improve and save lives with diagnostics. Ortho does that by reimagining what’s possible.

Headquartered in the U.S., the company’s 4,400 global employees serve customers in more than 125 countries and territories. Ortho ramped up investment in R&D (nearly $100 million annually, or more than 5% of sales), launched next-generation instruments for the Immunohematology and Clinical Labs markets and, by the end of 2018, will have launched more than 60 new or enhanced assays since becoming independent in 2014.

Featured is Pat Rigby of Ortho Care holding the company’s recent service awards, a MicroSlide testing environment, and the company’s next-generation analyzer, VITROS® XT 7600 Integrated System, which analyzes MicroSlide tests.

Innovation

  • In July 2018, Ortho achieved CE Mark for its VITROS® XT 7600 Integrated System, an automated, next-generation analyzer that detects diseases, conditions, and substances in the blood. Like other analyzers in Ortho’s VITROS portfolio, the VITROS XT uses the company’s proprietary dry slide technology, which does not require water or plumbing to operate.
  • Earlier this year, Ortho launched the VITROS® HIV Combo Test on its VITROS® 3600 analyzer in the U.S. HIV Combo is an innovative new test for HIV that enables disease detection earlier than previous generations of tests. Ortho also launched VITROS® NEPHROCHECK®1, the first automated test that can predict risk of deadly acute kidney injury in time for meaningful medical interventions to take place.
  • The company’s ORTHO VISION® and ORTHO VISION® Max analyzers bring automation to immunohematology—helping labs run more efficiently and effectively.

Talent Development

  • The company was recently recognized as a Great Place to Work by the Great Place to Work® Institute in India.
  • 98% of legacy employees followed Ortho as it became an independent company in 2014. Ortho has since added more than 2,200 employees.

Social Responsibility

  • Ortho’s Rochester, NY, manufacturing and R&D facilities saw a 26% reduction in water consumption from 2015 to 2017.
  • The company’s Pencoed, Wales, site in the U.K. achieved zero landfill status in 2016 and 2017.
  • Ortho’s VITROS® systems for the clinical lab do not require water or plumbing to run. The importance of this to the developing world, where water scarcity is often an issue and the likelihood of poor water quality is high and could affect test results, is clear. It’s why Ortho’s products are used on everything from aircraft carriers to humanitarian aid ships around the world.

Footnotes:

1. In development.

Ads

You May Also Like

Work Day Workouts for a Daily Refresh

When the cold weather arrives, we find ourselves hiding indoors, hunched over our desks ...

ELITE 2018 Transformational Leader Michele Schimmel of Marina Maher Communications and RXMOSAIC

Michele Schimmel Director of Healthcare Marina Maher Communications, RXMOSAIC The Turnaround Artist In 2015, ...